Advertisement

Related Videos

Varsha Gandhi, PhD, on Ibrutinib

Cody Peer, PhD, on Simulating Alternative Schedules for Checkpoint Inhibitors

Clifford A. Hudis, MD: Are Cancer Drug Prices in the U.S. the Problem or the Symptom?

David A. Hyman, MD, JD, on Inclusive Shared Savings

Mark Sculpher, PhD: How Do We Assess the Value of Cancer Drug Optimization?

Advertisement

Advertisement




Sep
21
Today In Oncology
TMC-I Regimen May Expand Treatment Access in Advanced Head and Neck Cancer
Mobile CT Lung Cancer Screening May Expand Access for Underserved Populations
ASTRO Issues Its First Clinical Guideline on Radiation Therapy for Bladder Cancer
Losing Weight and Breast Cancer Risk? The GLP-1 Question
FDA Approves Imlunestrant in Combination With Abemaciclib for ER-Positive, HER2-Negative, ESR1-Mutated Advanced or Metastatic Breast Cancer
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo